Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a multi-national cohort study including data from Denmark, Catalonia, and the United Kingdom
Summary This paper demonstrates a large post-fracture anti-osteoporosis treatment gap in the period 2005 to 2015. The gap was stable in Denmark at around 88–90%, increased in Catalonia from 80 to 88%, and started to increase in the UK towards the end of our study. Improved post-fracture care is need...
Saved in:
Published in | Osteoporosis international Vol. 31; no. 8; pp. 1535 - 1544 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Springer London
01.08.2020
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Summary
This paper demonstrates a large post-fracture anti-osteoporosis treatment gap in the period 2005 to 2015. The gap was stable in Denmark at around 88–90%, increased in Catalonia from 80 to 88%, and started to increase in the UK towards the end of our study. Improved post-fracture care is needed.
Introduction
Patients experiencing a fragility fracture are at high risk of subsequent fractures, particularly within the first 2 years after the fracture. Previous studies have demonstrated that only a small proportion of fracture patients initiate therapy with an anti-osteoporotic medication (AOM), despite the proven fracture risk reduction of such therapies. The aim of this paper is to evaluate the changes in this post-fracture treatment gap across three different countries from 2005 to 2015.
Methods
This analysis, which is part of a multinational cohort study, included men and women, aged 50 years or older, sustaining a first incident fragility fracture. Using routinely collected patient data from three administrative health databases covering Catalonia, Denmark, and the United Kingdom, we estimated the treatment gap as the proportion of patients not treated with AOM within 1 year of their first incident fracture.
Results
A total of 648,369 fracture patients were included. Mean age 70.2–78.9 years; 22.2–31.7% were men. In Denmark, the treatment gap was stable at approximately 88–90% throughout the 2005 to 2015 time period. In Catalonia, the treatment gap increased from 80 to 88%. In the UK, an initially decreasing treatment gap—though never smaller than 63%—was replaced by an increasing gap towards the end of our study. The gap was more pronounced in men than in women.
Conclusion
Despite repeated calls for improved secondary fracture prevention, an unacceptably large treatment gap remains, with time trends indicating that the problem may be getting worse in recent years. |
---|---|
AbstractList | This paper demonstrates a large post-fracture anti-osteoporosis treatment gap in the period 2005 to 2015. The gap was stable in Denmark at around 88-90%, increased in Catalonia from 80 to 88%, and started to increase in the UK towards the end of our study. Improved post-fracture care is needed.
Patients experiencing a fragility fracture are at high risk of subsequent fractures, particularly within the first 2 years after the fracture. Previous studies have demonstrated that only a small proportion of fracture patients initiate therapy with an anti-osteoporotic medication (AOM), despite the proven fracture risk reduction of such therapies. The aim of this paper is to evaluate the changes in this post-fracture treatment gap across three different countries from 2005 to 2015.
This analysis, which is part of a multinational cohort study, included men and women, aged 50 years or older, sustaining a first incident fragility fracture. Using routinely collected patient data from three administrative health databases covering Catalonia, Denmark, and the United Kingdom, we estimated the treatment gap as the proportion of patients not treated with AOM within 1 year of their first incident fracture.
A total of 648,369 fracture patients were included. Mean age 70.2-78.9 years; 22.2-31.7% were men. In Denmark, the treatment gap was stable at approximately 88-90% throughout the 2005 to 2015 time period. In Catalonia, the treatment gap increased from 80 to 88%. In the UK, an initially decreasing treatment gap-though never smaller than 63%-was replaced by an increasing gap towards the end of our study. The gap was more pronounced in men than in women.
Despite repeated calls for improved secondary fracture prevention, an unacceptably large treatment gap remains, with time trends indicating that the problem may be getting worse in recent years. Summary This paper demonstrates a large post-fracture anti-osteoporosis treatment gap in the period 2005 to 2015. The gap was stable in Denmark at around 88–90%, increased in Catalonia from 80 to 88%, and started to increase in the UK towards the end of our study. Improved post-fracture care is needed. Introduction Patients experiencing a fragility fracture are at high risk of subsequent fractures, particularly within the first 2 years after the fracture. Previous studies have demonstrated that only a small proportion of fracture patients initiate therapy with an anti-osteoporotic medication (AOM), despite the proven fracture risk reduction of such therapies. The aim of this paper is to evaluate the changes in this post-fracture treatment gap across three different countries from 2005 to 2015. Methods This analysis, which is part of a multinational cohort study, included men and women, aged 50 years or older, sustaining a first incident fragility fracture. Using routinely collected patient data from three administrative health databases covering Catalonia, Denmark, and the United Kingdom, we estimated the treatment gap as the proportion of patients not treated with AOM within 1 year of their first incident fracture. Results A total of 648,369 fracture patients were included. Mean age 70.2–78.9 years; 22.2–31.7% were men. In Denmark, the treatment gap was stable at approximately 88–90% throughout the 2005 to 2015 time period. In Catalonia, the treatment gap increased from 80 to 88%. In the UK, an initially decreasing treatment gap—though never smaller than 63%—was replaced by an increasing gap towards the end of our study. The gap was more pronounced in men than in women. Conclusion Despite repeated calls for improved secondary fracture prevention, an unacceptably large treatment gap remains, with time trends indicating that the problem may be getting worse in recent years. SummaryThis paper demonstrates a large post-fracture anti-osteoporosis treatment gap in the period 2005 to 2015. The gap was stable in Denmark at around 88–90%, increased in Catalonia from 80 to 88%, and started to increase in the UK towards the end of our study. Improved post-fracture care is needed.IntroductionPatients experiencing a fragility fracture are at high risk of subsequent fractures, particularly within the first 2 years after the fracture. Previous studies have demonstrated that only a small proportion of fracture patients initiate therapy with an anti-osteoporotic medication (AOM), despite the proven fracture risk reduction of such therapies. The aim of this paper is to evaluate the changes in this post-fracture treatment gap across three different countries from 2005 to 2015.MethodsThis analysis, which is part of a multinational cohort study, included men and women, aged 50 years or older, sustaining a first incident fragility fracture. Using routinely collected patient data from three administrative health databases covering Catalonia, Denmark, and the United Kingdom, we estimated the treatment gap as the proportion of patients not treated with AOM within 1 year of their first incident fracture.ResultsA total of 648,369 fracture patients were included. Mean age 70.2–78.9 years; 22.2–31.7% were men. In Denmark, the treatment gap was stable at approximately 88–90% throughout the 2005 to 2015 time period. In Catalonia, the treatment gap increased from 80 to 88%. In the UK, an initially decreasing treatment gap—though never smaller than 63%—was replaced by an increasing gap towards the end of our study. The gap was more pronounced in men than in women.ConclusionDespite repeated calls for improved secondary fracture prevention, an unacceptably large treatment gap remains, with time trends indicating that the problem may be getting worse in recent years. This paper demonstrates a large post-fracture anti-osteoporosis treatment gap in the period 2005 to 2015. The gap was stable in Denmark at around 88-90%, increased in Catalonia from 80 to 88%, and started to increase in the UK towards the end of our study. Improved post-fracture care is needed. INTRODUCTIONPatients experiencing a fragility fracture are at high risk of subsequent fractures, particularly within the first 2 years after the fracture. Previous studies have demonstrated that only a small proportion of fracture patients initiate therapy with an anti-osteoporotic medication (AOM), despite the proven fracture risk reduction of such therapies. The aim of this paper is to evaluate the changes in this post-fracture treatment gap across three different countries from 2005 to 2015. METHODSThis analysis, which is part of a multinational cohort study, included men and women, aged 50 years or older, sustaining a first incident fragility fracture. Using routinely collected patient data from three administrative health databases covering Catalonia, Denmark, and the United Kingdom, we estimated the treatment gap as the proportion of patients not treated with AOM within 1 year of their first incident fracture. RESULTSA total of 648,369 fracture patients were included. Mean age 70.2-78.9 years; 22.2-31.7% were men. In Denmark, the treatment gap was stable at approximately 88-90% throughout the 2005 to 2015 time period. In Catalonia, the treatment gap increased from 80 to 88%. In the UK, an initially decreasing treatment gap-though never smaller than 63%-was replaced by an increasing gap towards the end of our study. The gap was more pronounced in men than in women. CONCLUSIONDespite repeated calls for improved secondary fracture prevention, an unacceptably large treatment gap remains, with time trends indicating that the problem may be getting worse in recent years. |
Author | Abrahamsen, B. Libanati, C. Khalid, S. Javaid, M. K. Prieto-Alhambra, D. Toth, E. Rubin, K. H. Martinez-Laguna, D. Cooper, C. Skjødt, M. K. Ernst, M. Delmestri, A. |
Author_xml | – sequence: 1 givenname: M. K. surname: Skjødt fullname: Skjødt, M. K. organization: Department of Medicine, Hospital of Holbaek, Department of Medicine, Hospital of Slagelse, OPEN, Open Patient data Explorative Network, Odense University Hospital – sequence: 2 givenname: S. surname: Khalid fullname: Khalid, S. organization: Nuffield Orthopaedic Centre, Oxford University Hospitals – sequence: 3 givenname: M. surname: Ernst fullname: Ernst, M. organization: OPEN, Open Patient data Explorative Network, Odense University Hospital, Department of Public Health, Clinical Pharmacology and Pharmacy, University of Southern Denmark – sequence: 4 givenname: K. H. surname: Rubin fullname: Rubin, K. H. organization: OPEN, Open Patient data Explorative Network, Odense University Hospital – sequence: 5 givenname: D. surname: Martinez-Laguna fullname: Martinez-Laguna, D. organization: GREMPAL Research Group, Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), CIBERFES, Universitat Autònoma de Barcelona, Atenció Primària Barcelona Ciutat, Institut Català de la Salut – sequence: 6 givenname: A. surname: Delmestri fullname: Delmestri, A. organization: Nuffield Orthopaedic Centre, Oxford University Hospitals – sequence: 7 givenname: M. K. surname: Javaid fullname: Javaid, M. K. organization: Nuffield Orthopaedic Centre, Oxford University Hospitals – sequence: 8 givenname: C. surname: Cooper fullname: Cooper, C. organization: Nuffield Orthopaedic Centre, Oxford University Hospitals, MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital – sequence: 9 givenname: C. surname: Libanati fullname: Libanati, C. organization: UCB Pharma – sequence: 10 givenname: E. surname: Toth fullname: Toth, E. organization: UCB Pharma – sequence: 11 givenname: B. orcidid: 0000-0002-2730-6080 surname: Abrahamsen fullname: Abrahamsen, B. email: b.abrahamsen@physician.dk organization: Department of Medicine, Hospital of Holbaek, OPEN, Open Patient data Explorative Network, Odense University Hospital, Nuffield Orthopaedic Centre, Oxford University Hospitals – sequence: 12 givenname: D. surname: Prieto-Alhambra fullname: Prieto-Alhambra, D. organization: Nuffield Orthopaedic Centre, Oxford University Hospitals |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32185437$$D View this record in MEDLINE/PubMed |
BookMark | eNp9Ustu1DAUtVARnRZ-gAWyxIZFAzdxJnFYIKGhPEQlFhSJnXXHdmZcEjv4UWn-hp_gB_gynJlSHgtWlu55-Fz7nJAj66wm5GEJT0uA9lkAKDteQAUFLNmSF_Udsihrxoqqa5ZHZAEda4uuLj8fk5MQriCLuq69R45ZVfJlzdoF-f5RyzSgp9FrqwI1lsatzoeJBqNxlrp-nnicdjMYtHRWod_R3qOMyWs6eX2t7Z6bCefJu0k_p0jHNERT2L0LDlS6rfORhpjU7CSHpIzdUIURs5cb6SttR_RfzugqjwZnDZ5RtGqf51POo9WPb--zRLnxPrnb4xD0g5vzlFy-Pr9cvS0uPrx5t3p5Uci6rWMhGch1XynJew5Vw3UDCrHpWS8Rlsg5RwaNrHqlQHFZSSVhvUbImFSKs1Py4mA7pfWolcxbehzE5E0OuhMOjfgbsWYrNu5atKyBpu6ywZMbA---Jh2iGE2QehjQapeCqFibQ0DL20x9_A_1yiWfHy6z6oo1-bvYnKg6sKR3IXjd34YpQcylEIdSiFwKsS-FqLPo0Z9r3Ep-tSAT2IEQMmQ32v---z-2PwH1gMsc |
CitedBy_id | crossref_primary_10_1007_s00198_021_05890_x crossref_primary_10_1007_s00198_021_05911_9 crossref_primary_10_1007_s11657_022_01124_7 crossref_primary_10_2147_CEOR_S350790 crossref_primary_10_1007_s00223_021_00906_4 crossref_primary_10_1016_j_jbspin_2023_105574 crossref_primary_10_20960_RevOsteoporosMetabMiner_00017 crossref_primary_10_1007_s40520_021_01826_x crossref_primary_10_1016_j_rcot_2021_06_017 crossref_primary_10_1007_s40520_021_01844_9 crossref_primary_10_1016_j_jocd_2021_11_009 crossref_primary_10_1016_j_fmc_2023_08_003 crossref_primary_10_1016_j_rhum_2023_09_010 crossref_primary_10_1007_s11657_022_01174_x crossref_primary_10_1002_jbmr_4821 crossref_primary_10_1093_ageing_afac044 crossref_primary_10_1007_s00774_021_01236_z crossref_primary_10_1007_s00198_021_06284_9 crossref_primary_10_1111_hex_13361 crossref_primary_10_21518_2079_701X_2021_12_320_331 crossref_primary_10_1007_s00198_021_06165_1 crossref_primary_10_1016_j_fmc_2021_12_004 crossref_primary_10_2106_JBJS_OA_20_00142 crossref_primary_10_1007_s11657_024_01394_3 crossref_primary_10_57582_IJBF_220201_036 crossref_primary_10_5435_JAAOS_D_21_00185 crossref_primary_10_1007_s00198_021_06169_x crossref_primary_10_1002_jbmr_4414 crossref_primary_10_1007_s00198_023_06905_5 crossref_primary_10_1016_j_bone_2021_115934 crossref_primary_10_1016_j_jhqr_2024_03_004 crossref_primary_10_1016_j_imu_2023_101291 crossref_primary_10_1007_s00198_023_06759_x crossref_primary_10_1007_s40674_021_00190_1 |
Cites_doi | 10.1007/s11657-013-0136-1 10.1359/jbmr.2000.15.4.721 10.3109/13697137.2015.1045484 10.1056/NEJMoa022436 10.1007/s00198-018-4553-2 10.1016/j.bone.2004.03.024 10.1007/s00198-010-1359-2 10.1007/s00198-011-1630-1 10.1016/j.rceng.2015.08.005 10.1007/s00198-007-0483-0 10.1016/j.jocd.2015.01.005 10.1056/NEJM200105103441904 10.1007/s00198-018-4704-5 10.1007/s00198-017-4131-z 10.1007/s00198-016-3894-y 10.4055/cios.2016.8.3.274 10.1136/ard.2008.092775 10.1186/1471-2474-5-11 10.1002/jbmr.3877 10.1001/jama.282.7.637 10.1007/s00198-014-2827-x 10.1056/NEJMoa074941 10.1210/er.2018-00001 10.1016/j.spinee.2018.08.004 10.1016/j.semarthrit.2005.11.001 10.1007/s00198-012-2090-y 10.12809/hkmj187227 10.1503/cmaj.111158 10.1002/jbmr.2565 10.1002/14651858.CD003376.pub3 10.1002/14651858.CD001155.pub2 10.1002/14651858.CD004523.pub3 |
ContentType | Journal Article |
Copyright | The Author(s) 2020 The Author(s) 2020. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2020 – notice: The Author(s) 2020. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7QP 7RV 7TS 7X7 7XB 88E 8AO 8C1 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. KB0 M0S M1P NAPCQ PQEST PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.1007/s00198-020-05358-4 |
DatabaseName | Springer Nature OA Free Journals Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Nursing & Allied Health Database Physical Education Index Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) Medical Database Nursing & Allied Health Premium ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Public Health ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Pharma Collection ProQuest Central China ProQuest Hospital Collection (Alumni) Physical Education Index ProQuest Central Nursing & Allied Health Premium ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE ProQuest Public Health MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Databases url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1433-2965 |
EndPage | 1544 |
ExternalDocumentID | 10_1007_s00198_020_05358_4 32185437 |
Genre | Journal Article |
GeographicLocations | Denmark United Kingdom Europe Spain United Kingdom--UK |
GeographicLocations_xml | – name: United Kingdom – name: Denmark – name: Spain – name: Europe – name: United Kingdom--UK |
GrantInformation_xml | – fundername: UCB funderid: http://dx.doi.org/10.13039/100011110 – fundername: Medical Research Council grantid: G0400491 – fundername: Medical Research Council grantid: MC_UU_12011/1 – fundername: Medical Research Council grantid: MC_U147585824 – fundername: Medical Research Council grantid: MC_U147585819 – fundername: Department of Health grantid: 10/33/04 – fundername: Medical Research Council grantid: MC_UP_A620_1015 – fundername: Medical Research Council grantid: MC_U147585827 – fundername: Medical Research Council grantid: MC_UP_A620_1014 – fundername: Medical Research Council grantid: MC_UU_12011/2 – fundername: ; |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 123 199 1N0 1SB 203 28- 29O 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3V. 4.4 406 408 409 40D 40E 53G 5QI 5RE 5VS 67Z 6NX 78A 7RV 7X7 88E 8AO 8C1 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AABYN AAFGU AAHNG AAIAL AAJKR AAKSU AANXM AANZL AAPBV AARHV AARTL AATNV AATVU AAUYE AAWCG AAWTL AAYFA AAYIU AAYQN AAYTO ABBBX ABBXA ABDZT ABECU ABFGW ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKAS ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABOCM ABPLI ABPTK ABQBU ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACBMV ACBRV ACBXY ACBYP ACGFS ACHSB ACHXU ACIGE ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACTTH ACUDM ACVWB ACWMK ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADMDM ADOXG ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEEQQ AEFIE AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AESTI AETLH AEVLU AEVTX AEXYK AFAFS AFEXP AFKRA AFLOW AFNRJ AFQWF AFWTZ AFZKB AGAYW AGDGC AGGBP AGGDS AGJBK AGKHE AGMZJ AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AKMHD AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BKEYQ BPHCQ BVXVI C6C CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP EBD EBLON EBS EIOEI EJD EN4 ESBYG EX3 F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH L7B LAS LLZTM M1P M4Y MA- N2Q N9A NAPCQ NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RIG RNI RNS ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 WOW YLTOR Z45 Z7S Z7U Z7V Z7W Z7X Z81 Z82 Z83 Z87 Z8N Z8O Z8P Z8Q Z8U Z8V Z8W Z91 ZMTXR ZOVNA ZXP ~A9 ~EX ~KM AACDK AAEOY AAJBT AASML AAYZH ABAKF ACAOD ACDTI ACZOJ AEFQL AEMSY AFBBN AGQEE AGRTI AIGIU AJOOF ALIPV CGR CUY CVF ECM EIF EMB EMOBN H13 NPM SV3 AAYXX CITATION 7QP 7TS 7XB 8FK K9. PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c474t-c30cbf2dc8f80268e60daa6f3fca05a888a306c2fdd0d8c2cdc0bba005acdd83 |
IEDL.DBID | BENPR |
ISSN | 0937-941X |
IngestDate | Tue Sep 17 21:15:24 EDT 2024 Sat Oct 05 05:29:08 EDT 2024 Thu Oct 10 19:58:23 EDT 2024 Thu Sep 26 18:43:25 EDT 2024 Wed Oct 16 00:44:52 EDT 2024 Sat Dec 16 12:02:41 EST 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | Health Services Research Fracture prevention |
Language | English |
License | Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c474t-c30cbf2dc8f80268e60daa6f3fca05a888a306c2fdd0d8c2cdc0bba005acdd83 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-2730-6080 |
OpenAccessLink | https://doi.org/10.1007/s00198-020-05358-4 |
PMID | 32185437 |
PQID | 2423654338 |
PQPubID | 33762 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7360649 proquest_miscellaneous_2378880787 proquest_journals_2423654338 crossref_primary_10_1007_s00198_020_05358_4 pubmed_primary_32185437 springer_journals_10_1007_s00198_020_05358_4 |
PublicationCentury | 2000 |
PublicationDate | 2020-08-01 |
PublicationDateYYYYMMDD | 2020-08-01 |
PublicationDate_xml | – month: 08 year: 2020 text: 2020-08-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationSubtitle | With other metabolic bone diseases |
PublicationTitle | Osteoporosis international |
PublicationTitleAbbrev | Osteoporos Int |
PublicationTitleAlternate | Osteoporos Int |
PublicationYear | 2020 |
Publisher | Springer London Springer Nature B.V |
Publisher_xml | – name: Springer London – name: Springer Nature B.V |
References | Lyles, Colón-Emeric, Magaziner, Adachi, Pieper, Mautalen, Hyldstrup, Recknor, Nordsletten, Moore, Lavecchia, Zhang, Mesenbrink, Hodgson, Abrams, Orloff, Horowitz, Eriksen, Boonen (CR9) 2007; 357 Neer, Arnaud, Zanchetta, Prince, Gaich, Reginster, Hodsman, Eriksen, Ish-Shalom, Genant, Wang, Mitlak (CR11) 2001; 344 Kanis, Cooper, Rizzoli, Reginster (CR17) 2019; 30 Meunier, Roux, Seeman, Ortolani, Badurski, Spector, Cannata, Balogh, Lemmel, Pors-Nielsen, Rizzoli, Genant, Reginster (CR12) 2004; 350 Ettinger, Black, Mitlak, Knickerbocker, Nickelsen, Genant, Christiansen, Delmas, Zanchetta, Stakkestad, Glüer, Krueger, Cohen, Eckert, Ensrud, Avioli, Lips, Cummings (CR10) 1999; 282 Fraser, Ioannidis, Adachi, Pickard, Kaiser, Prior, Brown, Hanley, Olszynski, Anastassiades, Jamal, Josse, Goltzman, Papaioannou (CR21) 2011; 22 CR16 CR15 CR14 Ganda, Puech, Chen (CR35) 2013; 24 CR36 Leslie, LaBine, Klassen (CR37) 2012; 184 Papaioannou, Giangregorio, Kvern (CR19) 2004; 5 Nguyen, Posas-Mendoza, Siu, Ahn, Choi, Lim (CR28) 2018; 29 Palacios, Kalouche-Khalil, Rizzoli, Zapalowski, Resch, Adachi, Gallagher, Feldman, Kendler, Wang, Wagman, Adami (CR13) 2015; 18 Overman, Farley, Curtis, Zhang, Gourlay, Deal (CR34) 2015; 18 Conley, Adib, Adler (CR33) 2020; 35 Wilk, Sajjan, Modi, Fan, Mavros (CR22) 2014; 25 Barton, Behrend, Carmouche (CR25) 2019; 19 Cheung, Ho, Wong (CR24) 2018; 24 CR6 CR5 González-Macías, del Pino-Montes, Olmos (CR18) 2015; 215 CR7 CR27 Leslie, Giangregorio, Yogendran, Azimaee, Morin, Metge, Caetano, Lix (CR26) 2012; 23 Black, Abrahamsen, Bouxsein, Einhorn, Napoli (CR32) 2019; 40 Harvey, McCloskey, Mitchell (CR8) 2017; 28 Hernlund, Svedbom, Ivergård (CR1) 2013; 8 Kim, Choi, Kim, Oh (CR23) 2016; 8 Giangregorio, Papaioannou, Cranney, Zytaruk, Adachi (CR29) 2006; 35 Mendis, Ganda, Seibel (CR30) 2017; 28 Van Geel, Van Helden, Geusens (CR4) 2009; 68 Papaioannou, Kennedy, Ioannidis, Gao, Sawka, Goltzman, Tenenhouse, Pickard, Olszynski, Davison, Kaiser, Josse, Kreiger, Hanley, Prior, Brown, Anastassiades, Adachi (CR20) 2008; 19 Jha, Wang, Laucis, Bhattacharyya (CR31) 2015; 30 Klotzbuecher, Ross, Landsman, Abbott, Berger (CR2) 2000; 15 Kanis, Johnell, De Laet (CR3) 2004; 35 B Ettinger (5358_CR10) 1999; 282 ET Nguyen (5358_CR28) 2018; 29 5358_CR7 TI Kim (5358_CR23) 2016; 8 5358_CR5 5358_CR6 AS Mendis (5358_CR30) 2017; 28 5358_CR16 E Hernlund (5358_CR1) 2013; 8 5358_CR14 DM Black (5358_CR32) 2019; 40 5358_CR36 5358_CR15 J Kanis (5358_CR17) 2019; 30 K Ganda (5358_CR35) 2013; 24 LA Fraser (5358_CR21) 2011; 22 A Papaioannou (5358_CR19) 2004; 5 M Cheung (5358_CR24) 2018; 24 S Palacios (5358_CR13) 2015; 18 NC Harvey (5358_CR8) 2017; 28 CM Klotzbuecher (5358_CR2) 2000; 15 JA Kanis (5358_CR3) 2004; 35 A Papaioannou (5358_CR20) 2008; 19 PJ Meunier (5358_CR12) 2004; 350 J González-Macías (5358_CR18) 2015; 215 S Jha (5358_CR31) 2015; 30 KW Lyles (5358_CR9) 2007; 357 5358_CR27 WD Leslie (5358_CR26) 2012; 23 T Van Geel (5358_CR4) 2009; 68 L Giangregorio (5358_CR29) 2006; 35 RM Neer (5358_CR11) 2001; 344 RA Overman (5358_CR34) 2015; 18 DW Barton (5358_CR25) 2019; 19 RB Conley (5358_CR33) 2020; 35 WD Leslie (5358_CR37) 2012; 184 A Wilk (5358_CR22) 2014; 25 |
References_xml | – volume: 8 start-page: 1 year: 2013 end-page: 115 ident: CR1 article-title: Osteoporosis in the European Union: medical management, epidemiology and economic burden: a report prepared in collaboration with the international Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA) publication-title: Arch Osteoporos doi: 10.1007/s11657-013-0136-1 contributor: fullname: Ivergård – volume: 15 start-page: 721 year: 2000 end-page: 739 ident: CR2 article-title: Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis publication-title: J Bone Miner Res doi: 10.1359/jbmr.2000.15.4.721 contributor: fullname: Berger – volume: 18 start-page: 805 year: 2015 end-page: 812 ident: CR13 article-title: Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis publication-title: Climacteric doi: 10.3109/13697137.2015.1045484 contributor: fullname: Adami – volume: 350 start-page: 459 year: 2004 end-page: 468 ident: CR12 article-title: The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis publication-title: N Engl J Med doi: 10.1056/NEJMoa022436 contributor: fullname: Reginster – volume: 29 start-page: 1827 year: 2018 end-page: 1832 ident: CR28 article-title: Low rates of osteoporosis treatment after hospitalization for hip fracture in Hawaii publication-title: Osteoporos Int doi: 10.1007/s00198-018-4553-2 contributor: fullname: Lim – ident: CR14 – volume: 35 start-page: 375 year: 2004 end-page: 382 ident: CR3 article-title: A meta-analysis of previous fracture and subsequent fracture risk publication-title: Bone doi: 10.1016/j.bone.2004.03.024 contributor: fullname: De Laet – ident: CR16 – volume: 22 start-page: 789 year: 2011 end-page: 796 ident: CR21 article-title: Fragility fractures and the osteoporosis care gap in women: the Canadian Multicentre Osteoporosis Study publication-title: Osteoporos Int doi: 10.1007/s00198-010-1359-2 contributor: fullname: Papaioannou – volume: 23 start-page: 1623 year: 2012 end-page: 1629 ident: CR26 article-title: A population-based analysis of the post-fracture care gap 1996-2008: the situation is not improving publication-title: Osteoporos Int doi: 10.1007/s00198-011-1630-1 contributor: fullname: Lix – ident: CR6 – volume: 215 start-page: 515 year: 2015 end-page: 526 ident: CR18 article-title: Clinical practice guidelines for postmenopausal, glucocorticoid-induced and male osteoporosis. Spanish Society for Research on Bone and Mineral Metabolism (3rd updated version 2014) publication-title: Rev Clin Esp doi: 10.1016/j.rceng.2015.08.005 contributor: fullname: Olmos – volume: 19 start-page: 581 year: 2008 end-page: 587 ident: CR20 article-title: The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study publication-title: Osteoporos Int doi: 10.1007/s00198-007-0483-0 contributor: fullname: Adachi – volume: 18 start-page: 145 year: 2015 end-page: 149 ident: CR34 article-title: DXA utilization between 2006 and 2012 in commercially insured younger postmenopausal women publication-title: J Clin Densitom doi: 10.1016/j.jocd.2015.01.005 contributor: fullname: Deal – volume: 344 start-page: 1434 year: 2001 end-page: 1441 ident: CR11 article-title: Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis publication-title: N Engl J Med doi: 10.1056/NEJM200105103441904 contributor: fullname: Mitlak – volume: 30 start-page: 3 year: 2019 end-page: 44 ident: CR17 article-title: Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF). European guidance for the diagnosis and management of osteoporosis in postmenopausal women publication-title: Osteoporos Int doi: 10.1007/s00198-018-4704-5 contributor: fullname: Reginster – ident: CR27 – volume: 28 start-page: 2913 year: 2017 end-page: 2919 ident: CR30 article-title: Barriers to secondary fracture prevention in primary care publication-title: Osteoporos Int doi: 10.1007/s00198-017-4131-z contributor: fullname: Seibel – volume: 28 start-page: 1507 year: 2017 end-page: 1529 ident: CR8 article-title: Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures publication-title: Osteoporos Int doi: 10.1007/s00198-016-3894-y contributor: fullname: Mitchell – volume: 8 start-page: 274 year: 2016 end-page: 279 ident: CR23 article-title: The adequacy of diagnosis and treatment for osteoporosis in patients with proximal humeral fractures publication-title: Clin Orthop Surg doi: 10.4055/cios.2016.8.3.274 contributor: fullname: Oh – volume: 68 start-page: 99 year: 2009 end-page: 102 ident: CR4 article-title: Clinical subsequent fractures cluster in time after first fractures publication-title: Ann Rheum Dis doi: 10.1136/ard.2008.092775 contributor: fullname: Geusens – volume: 5 start-page: 1 year: 2004 end-page: 6 ident: CR19 article-title: The osteoporosis care gap in Canada publication-title: BMC Musculoskelet Disord doi: 10.1186/1471-2474-5-11 contributor: fullname: Kvern – volume: 35 start-page: 36 year: 2020 end-page: 52 ident: CR33 article-title: Secondary fracture prevention: consensus clinical recommendations from a multistakeholder coalition publication-title: J Bone Miner Res doi: 10.1002/jbmr.3877 contributor: fullname: Adler – volume: 282 start-page: 637 year: 1999 end-page: 645 ident: CR10 article-title: Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial publication-title: JAMA doi: 10.1001/jama.282.7.637 contributor: fullname: Cummings – volume: 25 start-page: 2777 year: 2014 end-page: 2786 ident: CR22 article-title: Post-fracture pharmacotherapy for women with osteoporotic fracture: analysis of a managed care population in the USA publication-title: Osteoporos Int doi: 10.1007/s00198-014-2827-x contributor: fullname: Mavros – volume: 357 start-page: 1799 year: 2007 end-page: 1809 ident: CR9 article-title: Zoledronic acid and clinical fractures and mortality after hip fracture publication-title: N Engl J Med doi: 10.1056/NEJMoa074941 contributor: fullname: Boonen – ident: CR15 – volume: 40 start-page: 333 year: 2019 end-page: 368 ident: CR32 article-title: Atypical femur fractures: review of epidemiology, relationship to bisphosphonates, prevention, and clinical management publication-title: Endocr Rev doi: 10.1210/er.2018-00001 contributor: fullname: Napoli – volume: 19 start-page: 411 year: 2019 end-page: 417 ident: CR25 article-title: Rates of osteoporosis screening and treatment following vertebral fracture publication-title: Spine J doi: 10.1016/j.spinee.2018.08.004 contributor: fullname: Carmouche – volume: 35 start-page: 293 year: 2006 end-page: 305 ident: CR29 article-title: Fragility fractures and the osteoporosis care gap: an international phenomenon publication-title: Semin Arthritis Rheum doi: 10.1016/j.semarthrit.2005.11.001 contributor: fullname: Adachi – volume: 24 start-page: 393 year: 2013 end-page: 406 ident: CR35 article-title: Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis publication-title: Osteoporos Int doi: 10.1007/s00198-012-2090-y contributor: fullname: Chen – volume: 24 start-page: 579 year: 2018 end-page: 583 ident: CR24 article-title: Post-fracture care gap: a retrospective population-based analysis of Hong Kong from 2009 to 2012 publication-title: Hong Kong Med J doi: 10.12809/hkmj187227 contributor: fullname: Wong – ident: CR36 – ident: CR5 – volume: 184 start-page: 290 year: 2012 end-page: 296 ident: CR37 article-title: Closing the gap in postfracture care at the population level: a randomized controlled trial publication-title: Can Med Assoc J doi: 10.1503/cmaj.111158 contributor: fullname: Klassen – ident: CR7 – volume: 30 start-page: 2179 year: 2015 end-page: 2187 ident: CR31 article-title: Trends in media reports, oral bisphosphonate prescriptions, and hip fractures 1996-2012: an ecological analysis publication-title: J Bone Miner Res doi: 10.1002/jbmr.2565 contributor: fullname: Bhattacharyya – volume: 357 start-page: 1799 year: 2007 ident: 5358_CR9 publication-title: N Engl J Med doi: 10.1056/NEJMoa074941 contributor: fullname: KW Lyles – volume: 19 start-page: 581 year: 2008 ident: 5358_CR20 publication-title: Osteoporos Int doi: 10.1007/s00198-007-0483-0 contributor: fullname: A Papaioannou – volume: 350 start-page: 459 year: 2004 ident: 5358_CR12 publication-title: N Engl J Med doi: 10.1056/NEJMoa022436 contributor: fullname: PJ Meunier – volume: 215 start-page: 515 year: 2015 ident: 5358_CR18 publication-title: Rev Clin Esp doi: 10.1016/j.rceng.2015.08.005 contributor: fullname: J González-Macías – volume: 19 start-page: 411 year: 2019 ident: 5358_CR25 publication-title: Spine J doi: 10.1016/j.spinee.2018.08.004 contributor: fullname: DW Barton – ident: 5358_CR36 – volume: 35 start-page: 36 year: 2020 ident: 5358_CR33 publication-title: J Bone Miner Res doi: 10.1002/jbmr.3877 contributor: fullname: RB Conley – volume: 24 start-page: 393 year: 2013 ident: 5358_CR35 publication-title: Osteoporos Int doi: 10.1007/s00198-012-2090-y contributor: fullname: K Ganda – ident: 5358_CR7 doi: 10.1002/14651858.CD003376.pub3 – volume: 344 start-page: 1434 year: 2001 ident: 5358_CR11 publication-title: N Engl J Med doi: 10.1056/NEJM200105103441904 contributor: fullname: RM Neer – ident: 5358_CR15 – volume: 18 start-page: 805 year: 2015 ident: 5358_CR13 publication-title: Climacteric doi: 10.3109/13697137.2015.1045484 contributor: fullname: S Palacios – volume: 25 start-page: 2777 year: 2014 ident: 5358_CR22 publication-title: Osteoporos Int doi: 10.1007/s00198-014-2827-x contributor: fullname: A Wilk – volume: 24 start-page: 579 year: 2018 ident: 5358_CR24 publication-title: Hong Kong Med J doi: 10.12809/hkmj187227 contributor: fullname: M Cheung – volume: 23 start-page: 1623 year: 2012 ident: 5358_CR26 publication-title: Osteoporos Int doi: 10.1007/s00198-011-1630-1 contributor: fullname: WD Leslie – volume: 184 start-page: 290 year: 2012 ident: 5358_CR37 publication-title: Can Med Assoc J doi: 10.1503/cmaj.111158 contributor: fullname: WD Leslie – volume: 18 start-page: 145 year: 2015 ident: 5358_CR34 publication-title: J Clin Densitom doi: 10.1016/j.jocd.2015.01.005 contributor: fullname: RA Overman – ident: 5358_CR27 – volume: 40 start-page: 333 year: 2019 ident: 5358_CR32 publication-title: Endocr Rev doi: 10.1210/er.2018-00001 contributor: fullname: DM Black – volume: 68 start-page: 99 year: 2009 ident: 5358_CR4 publication-title: Ann Rheum Dis doi: 10.1136/ard.2008.092775 contributor: fullname: T Van Geel – volume: 30 start-page: 2179 year: 2015 ident: 5358_CR31 publication-title: J Bone Miner Res doi: 10.1002/jbmr.2565 contributor: fullname: S Jha – volume: 30 start-page: 3 year: 2019 ident: 5358_CR17 publication-title: Osteoporos Int doi: 10.1007/s00198-018-4704-5 contributor: fullname: J Kanis – volume: 15 start-page: 721 year: 2000 ident: 5358_CR2 publication-title: J Bone Miner Res doi: 10.1359/jbmr.2000.15.4.721 contributor: fullname: CM Klotzbuecher – ident: 5358_CR16 – volume: 22 start-page: 789 year: 2011 ident: 5358_CR21 publication-title: Osteoporos Int doi: 10.1007/s00198-010-1359-2 contributor: fullname: LA Fraser – ident: 5358_CR5 doi: 10.1002/14651858.CD001155.pub2 – ident: 5358_CR14 – volume: 29 start-page: 1827 year: 2018 ident: 5358_CR28 publication-title: Osteoporos Int doi: 10.1007/s00198-018-4553-2 contributor: fullname: ET Nguyen – volume: 282 start-page: 637 year: 1999 ident: 5358_CR10 publication-title: JAMA doi: 10.1001/jama.282.7.637 contributor: fullname: B Ettinger – ident: 5358_CR6 doi: 10.1002/14651858.CD004523.pub3 – volume: 28 start-page: 1507 year: 2017 ident: 5358_CR8 publication-title: Osteoporos Int doi: 10.1007/s00198-016-3894-y contributor: fullname: NC Harvey – volume: 8 start-page: 274 year: 2016 ident: 5358_CR23 publication-title: Clin Orthop Surg doi: 10.4055/cios.2016.8.3.274 contributor: fullname: TI Kim – volume: 28 start-page: 2913 year: 2017 ident: 5358_CR30 publication-title: Osteoporos Int doi: 10.1007/s00198-017-4131-z contributor: fullname: AS Mendis – volume: 35 start-page: 293 year: 2006 ident: 5358_CR29 publication-title: Semin Arthritis Rheum doi: 10.1016/j.semarthrit.2005.11.001 contributor: fullname: L Giangregorio – volume: 8 start-page: 1 year: 2013 ident: 5358_CR1 publication-title: Arch Osteoporos doi: 10.1007/s11657-013-0136-1 contributor: fullname: E Hernlund – volume: 35 start-page: 375 year: 2004 ident: 5358_CR3 publication-title: Bone doi: 10.1016/j.bone.2004.03.024 contributor: fullname: JA Kanis – volume: 5 start-page: 1 year: 2004 ident: 5358_CR19 publication-title: BMC Musculoskelet Disord doi: 10.1186/1471-2474-5-11 contributor: fullname: A Papaioannou |
SSID | ssj0007997 |
Score | 2.522384 |
Snippet | Summary
This paper demonstrates a large post-fracture anti-osteoporosis treatment gap in the period 2005 to 2015. The gap was stable in Denmark at around... This paper demonstrates a large post-fracture anti-osteoporosis treatment gap in the period 2005 to 2015. The gap was stable in Denmark at around 88-90%,... SummaryThis paper demonstrates a large post-fracture anti-osteoporosis treatment gap in the period 2005 to 2015. The gap was stable in Denmark at around... |
SourceID | pubmedcentral proquest crossref pubmed springer |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 1535 |
SubjectTerms | Aged Bone Density Conservation Agents - therapeutic use Cohort analysis Cohort Studies Denmark - epidemiology Endocrinology Europe - epidemiology Female Fractures Humans Male Medicine Medicine & Public Health Middle Aged Original Original Article Orthopedics Osteoporosis Osteoporotic Fractures - epidemiology Osteoporotic Fractures - prevention & control Rheumatology Spain - epidemiology Trends United Kingdom - epidemiology |
SummonAdditionalLinks | – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSIgL4k2gICNxYy0lsfPihhaqCqlcKNLeovFLrKDeKs0e-m_4E_wBfhkzdjZoWzhwysGT59iZbzwz3zD22kLr0W52wndEql1WWkBhtHBeg-tsrlOF3Mmn-viL-riqVhNNDtXCXInfE9lnQUVgJYVsZdUKdZPdqoo6pxm8rJfzX7fpYiMVdNAb0aliNRXI_P0a-0boGrK8niB5JUoajc_RPXZ3Qo38XVLzfXbDhQfs9skUF3_Ifn5OPW75GFNc-TpwBHZ4WI_p0_ON56nU6pIGL8gNtjBcck9VUtvB8fOJywllUSBt0r_lwGPGodjtGXJqqDuMPLLSoqD5viXjxynRlFOpCn_vwhkM3xZ8GTeGwhoWHIKNz5MA7q8f1EjFbs4esdOjD6fLYzE1ZBBGNWoURuZG-9Ka1rfou7Wuzi1A7aU3kFeAzjSgB2JKb21uW1Maa3KtARc6GGtb-ZgdhE1wTxlHVFropnOgrEJAlkMhfeU8uk8SraeuMvZmp6D-PNFu9DPBclRnj-rsozp7lbHDnQ77aQle9AQUqXBWthl7NQ_j4qGICAS32aIMsekT436TsSdJ5fPtJIIfPB1Hmr3JMAsQMff-SFh_jQTdjUS3UHUZW-ymzZ_H-vdbPPs_8efsThmnNCUjHrKDcdi6FwiQRv0yrozfzZoNNA priority: 102 providerName: Springer Nature |
Title | Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a multi-national cohort study including data from Denmark, Catalonia, and the United Kingdom |
URI | https://link.springer.com/article/10.1007/s00198-020-05358-4 https://www.ncbi.nlm.nih.gov/pubmed/32185437 https://www.proquest.com/docview/2423654338 https://search.proquest.com/docview/2378880787 https://pubmed.ncbi.nlm.nih.gov/PMC7360649 |
Volume | 31 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9NAEF7RRkJcEG8MJVokbmSFH-vY5oISk1CBGiFopXCy9ikiqB0c59D_xQ9kZv2oQgUX-zBj2dbs7ry_IeSVFqkFvZkxmyGodhhLJgIlmbFSmEz7su2QO1tNTy_4x3W87gJuu66ssj8T3UGtK4Ux8jeo97EPMkrfbX8xnBqF2dVuhMYRGYUBxzTtaL5Yff4ynMVJ5sargNuesIwH665txjXPoXWTMnSfEOMkZfxQNd2wN2-WTf6VO3UqaXmP3O1sSTprhX-f3DLlA3L7rMuWPyS_v7aTb2njCl_ppqRg7sFt07QCoZWlbQPWFRJ36BxrUV9Ri71T-9rQbYfwBLzA0Ibu31JBXR0i6yOJFMfs1g11WLXAqH7uUSVSLD-l2MBC35vyUtQ_JjR34aJyIyZUlNp9T2v2UpyuoqvLR-R8uTjPT1k3pYEpnvCGqchX0oZapTYFhy41U18LMbWRVcKPBXjYAtwSFVqtfZ2qUGnlSylg9wuldRo9JsdlVZqnhIKpGsgkM4JrDlaaL4LIxsaCTxWBSpWxR1738im2LRZHMaAuO2kWIM3CSbPgHjnpRVh0-3JXXK8ij7wcyLCjME0iSlPtgQch9hGGP_HIk1biw-sisIjgcaAkB2thYEC07kNKufnuULuTCHxFnnlk0q-a68_69188-_9fPCd3QreCsSLxhBw39d68ACupkWNylKwTuKZ5MCaj2XI-X-H9w7dPi3G3TYCaT3O4XoSzPznyGwo |
link.rule.ids | 230,315,786,790,891,12083,12250,21416,27955,27956,31752,31753,33299,33300,33777,33778,41114,41153,41556,42183,42222,42625,43343,43612,43838,51609,52144,52267,74100,74369,74657 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwELZgkYAL4k1ggUHiRi3SxGkcLggVVgW2e6FIvUV-aivYpKTpYf8XP5AZJ2lVVnDKwRPF0dieb8Yz3zD22irp0W4W3BdEqp1kmqux0dx5rVxhY91VyM3PJrPv4ssyW_YBt02fVjmcieGgtrWhGPlbsvtUB5nK9-tfnLpG0e1q30LjOrshUrTVVCk-3ad45EVoroJOe84LMV72RTOhdI6wjeTkPBHDieTi0DBdQZtXkyb_ujkNBunkLrvTI0n40Kn-Hrvmqvvs5ry_K3_Afn_r-t5CG9JeYVUBgj18rNpOHVB76MqvLmlwQ66xVc0leKqc2jYO1j2_E8qiQBe4fwcKQhYiH-KIQE12mxYCUy0Kmp9bMohAyadA5Svw0VUXqvkxgmkIFlUrNQJV2TCfDvQC9Vax9cVDtjj5tJjOeN-jgRuRi5abNDbaJ9ZIL9Gdk24SW6UmPvVGxZlC_1qhU2ISb21spUmMNbHWCve-MtbK9BE7qurKPWGAQHWs88IpYQVitFiNU585jx5VigZVZxF7M-inXHdMHOWOczlos0RtlkGbpYjY8aDCst-Vm3K_hiL2ajeM-4kuSVTl6i3KEME-kfDnEXvcaXz3uRTxEL6OI_nBWtgJEFf34Ui1Og-c3XmKnqIoIjYaVs1-Wv_-i6f__4uX7NZsMT8tTz-ffX3GbidhNVNu4jE7apute454qdUvwqb4A7ciFdI |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9NAEF5BkSouiDcuBQaJG1nV8SNec0EoJSqPVkgUKTdrn2oEtVPHOfR_8QOZWa8ThQpOPuxYXmtmd2Z2v_mGsTdGCod-s-SuJFLtJFdcjrXi1ilpSxOrvkLu9Gxy8iP7PM_nAf-0CrDKYU_0G7VpNJ2RH5HfpzrIVBy5AIv4djx7v7zi1EGKblpDO43b7A56xQlZuJhu4R5F6RutYAJf8DIbz0MBjS-jozhHcEqkiO1E8GzXSd2IPG8CKP-6RfXOaXaf3QtRJXzozeABu2Xrh2z_NNybP2K_v_c9cKHzEFhY1ICBHz4WXa8aaBz0pVjXNLiiNNnI9hocVVGtWwvLwPWEsijQH-K_AwkekciHM0WghrttB561FgX1rzU5RyAgKlApCxzb-lK2P0cw9QdH9UKOQNbGz6cPgIH6rJjm8jE7n308n57w0K-B66zIOq7TWCuXGC2cwNRO2ElspJy41GkZ5xJzbYkJik6cMbEROtFGx0pJ3AekNkakT9he3dT2GQMMWseqKK3MTIbxWizHqcutw-wqReeq8oi9HfRTLXtWjmrDv-y1WaE2K6_NKovY4aDCKqzQVbW1p4i93gzj2qILE1nbZo0yRLZPhPxFxJ72Gt98LsXYCF_HkWLHFjYCxNu9O1IvLjx_d5Fi1piVERsNVrOd1r__4uD_f_GK7eN6qL5-OvvynN1NvDETTPGQ7XXt2r7A0KlTL_2a-APM-BoQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Secular+trends+in+the+initiation+of+therapy+in+secondary+fracture+prevention+in+Europe%3A+a+multi-national+cohort+study+including+data+from+Denmark%2C+Catalonia%2C+and+the+United+Kingdom&rft.jtitle=Osteoporosis+international&rft.au=Skj%C3%B8dt%2C+M+K&rft.au=Khalid%2C+S&rft.au=Ernst%2C+M&rft.au=Rubin%2C+K+H&rft.date=2020-08-01&rft.pub=Springer+Nature+B.V&rft.issn=0937-941X&rft.eissn=1433-2965&rft.volume=31&rft.issue=8&rft.spage=1535&rft.epage=1544&rft_id=info:doi/10.1007%2Fs00198-020-05358-4&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0937-941X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0937-941X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0937-941X&client=summon |